LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 92.98 | 84.90 | 11195 | 7257 | 1.5425 | 1.1397 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 94.68 | 84.90 | 2358 | 7000 | 0.3368 | 0.6857 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 94.68 | 84.90 | 9746 | 7000 | 1.3922 | 1.1067 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 94.68 | 84.90 | 494 | 7000 | 0.0706 | 0.3187 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 94.68 | 84.90 | 11528 | 7000 | 1.6468 | 1.1630 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 2.66 | 84.90 | 545 | 285 | 1.9073 | 1.8920 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 2.66 | 84.90 | 524 | 285 | 1.8338 | 1.8278 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 4.36 | 84.90 | 630 | 322 | 1.9531 | 1.8313 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 4.36 | 84.90 | 654 | 322 | 2.0275 | 1.8868 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 6.06 | 84.90 | 3 | 365 | 0.0082 | -0.7955 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 6.06 | 84.90 | 700 | 365 | 1.9154 | 1.7231 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 6.06 | 84.90 | 701 | 365 | 1.9182 | 1.7250 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 7.77 | 84.90 | 6 | 411 | 0.0146 | -0.6878 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 7.77 | 84.90 | 785 | 411 | 1.9089 | 1.6570 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 7.77 | 84.90 | 821 | 411 | 1.9964 | 1.7098 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 9.47 | 84.90 | 8 | 447 | 0.0179 | -0.6266 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 9.47 | 84.90 | 856 | 447 | 1.9132 | 1.6214 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 9.47 | 84.90 | 5 | 447 | 0.0112 | -0.6930 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 9.47 | 84.90 | 887 | 447 | 1.9824 | 1.6606 | MN20160318_Q02 | D18 |